US Patent 11969485 Controlled release of radionuclides
Patent 11969485 was granted and assigned to Alpha Tau Medical on April, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 1 May, 2024
Golden AI
Edits made to:
Infobox (+33 properties)
Article (+605 characters)
US Patent 11969485 Controlled release of radionuclides
Article
Patent abstract
A brachytherapy device including a base adapted for being at least partially introduced into a body of a subject and a plurality of radionuclide atoms of a first alpha-emitting isotope, coupled to the base in a manner that not more than 15% of the radionuclide atoms leave the base in 24 hours, in methods other than radioactive decay. When installed in a human subject, the brachytherapy device emits radionuclide atoms of the first alpha-emitting isotope at a rate of at least 0.1% of the number of radionuclide atoms of the first alpha-emitting isotope coupled to the base, per 24 hours.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Amitai Sosnovitch0
Amnon Gat0
Avia Berkowitz0
Guy Keret0
Itzhak Kelson0
Michael Schmidt0
Ofer Magen0
Yona Keisari0
Date of Patent
April 30, 2024
0Patent Application Number
169795430
Date Filed
March 28, 2019
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11969485 Controlled release of radionuclides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
